Genetic basis of hypercholesterolemia in adults

Abstract We investigated monogenic and polygenic causes of hypercholesterolemia in a population-based cohort, excluding secondary hypercholesterolemia, and using an established framework to identify pathogenic variants. We studied 1682 individuals (50.2 ± 8.6 years, 41.3% males) from southeast Minne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seyedmohammad Saadatagah, Merin Jose, Ozan Dikilitas, Lubna Alhabi, Alexandra A. Miller, Xiao Fan, Janet E. Olson, David C. Kochan, Maya Safarova, Iftikhar J. Kullo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Acceso en línea:https://doaj.org/article/5c962de15c504427a84a1f17c57c7dba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5c962de15c504427a84a1f17c57c7dba
record_format dspace
spelling oai:doaj.org-article:5c962de15c504427a84a1f17c57c7dba2021-12-02T14:27:46ZGenetic basis of hypercholesterolemia in adults10.1038/s41525-021-00190-z2056-7944https://doaj.org/article/5c962de15c504427a84a1f17c57c7dba2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41525-021-00190-zhttps://doaj.org/toc/2056-7944Abstract We investigated monogenic and polygenic causes of hypercholesterolemia in a population-based cohort, excluding secondary hypercholesterolemia, and using an established framework to identify pathogenic variants. We studied 1682 individuals (50.2 ± 8.6 years, 41.3% males) from southeast Minnesota with primary hypercholesterolemia (low-density lipoprotein cholesterol (LDL-C) ≥155 mg/dl in the absence of identifiable secondary causes). Familial hypercholesterolemia (FH) phenotype was defined as a Dutch Lipid Clinic Network (DLCN) score ≥6. Participants underwent sequencing of LDLR, APOB, and PCSK9, and genotyping of 12 LDL-C-associated single-nucleotide variants to construct a polygenic score (PGS) for LDL-C. The presence of a pathogenic/likely pathogenic variant was considered monogenic etiology and a PGS ≥90th percentile was considered polygenic etiology. The mean LDL-C level was 187.3 ± 32.3 mg/dl and phenotypic FH was present in 8.4% of the cohort. An identifiable genetic etiology was present in 17.1% individuals (monogenic in 1.5% and polygenic in 15.6%). Phenotypic and genetic FH showed poor overlap. Only 26% of those who met the clinical criteria of FH had an identifiable genetic etiology and of those with an identifiable genetic etiology only 12.9% met clinical criteria for FH. Genetic factors explained 7.4% of the variance in LDL-C. In conclusion, in adults with primary hypercholesterolemia, 17.1% had an identifiable genetic etiology and the overlap between phenotypic and genetic FH was modest.Seyedmohammad SaadatagahMerin JoseOzan DikilitasLubna AlhabiAlexandra A. MillerXiao FanJanet E. OlsonDavid C. KochanMaya SafarovaIftikhar J. KulloNature PortfolioarticleMedicineRGeneticsQH426-470ENnpj Genomic Medicine, Vol 6, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Genetics
QH426-470
spellingShingle Medicine
R
Genetics
QH426-470
Seyedmohammad Saadatagah
Merin Jose
Ozan Dikilitas
Lubna Alhabi
Alexandra A. Miller
Xiao Fan
Janet E. Olson
David C. Kochan
Maya Safarova
Iftikhar J. Kullo
Genetic basis of hypercholesterolemia in adults
description Abstract We investigated monogenic and polygenic causes of hypercholesterolemia in a population-based cohort, excluding secondary hypercholesterolemia, and using an established framework to identify pathogenic variants. We studied 1682 individuals (50.2 ± 8.6 years, 41.3% males) from southeast Minnesota with primary hypercholesterolemia (low-density lipoprotein cholesterol (LDL-C) ≥155 mg/dl in the absence of identifiable secondary causes). Familial hypercholesterolemia (FH) phenotype was defined as a Dutch Lipid Clinic Network (DLCN) score ≥6. Participants underwent sequencing of LDLR, APOB, and PCSK9, and genotyping of 12 LDL-C-associated single-nucleotide variants to construct a polygenic score (PGS) for LDL-C. The presence of a pathogenic/likely pathogenic variant was considered monogenic etiology and a PGS ≥90th percentile was considered polygenic etiology. The mean LDL-C level was 187.3 ± 32.3 mg/dl and phenotypic FH was present in 8.4% of the cohort. An identifiable genetic etiology was present in 17.1% individuals (monogenic in 1.5% and polygenic in 15.6%). Phenotypic and genetic FH showed poor overlap. Only 26% of those who met the clinical criteria of FH had an identifiable genetic etiology and of those with an identifiable genetic etiology only 12.9% met clinical criteria for FH. Genetic factors explained 7.4% of the variance in LDL-C. In conclusion, in adults with primary hypercholesterolemia, 17.1% had an identifiable genetic etiology and the overlap between phenotypic and genetic FH was modest.
format article
author Seyedmohammad Saadatagah
Merin Jose
Ozan Dikilitas
Lubna Alhabi
Alexandra A. Miller
Xiao Fan
Janet E. Olson
David C. Kochan
Maya Safarova
Iftikhar J. Kullo
author_facet Seyedmohammad Saadatagah
Merin Jose
Ozan Dikilitas
Lubna Alhabi
Alexandra A. Miller
Xiao Fan
Janet E. Olson
David C. Kochan
Maya Safarova
Iftikhar J. Kullo
author_sort Seyedmohammad Saadatagah
title Genetic basis of hypercholesterolemia in adults
title_short Genetic basis of hypercholesterolemia in adults
title_full Genetic basis of hypercholesterolemia in adults
title_fullStr Genetic basis of hypercholesterolemia in adults
title_full_unstemmed Genetic basis of hypercholesterolemia in adults
title_sort genetic basis of hypercholesterolemia in adults
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5c962de15c504427a84a1f17c57c7dba
work_keys_str_mv AT seyedmohammadsaadatagah geneticbasisofhypercholesterolemiainadults
AT merinjose geneticbasisofhypercholesterolemiainadults
AT ozandikilitas geneticbasisofhypercholesterolemiainadults
AT lubnaalhabi geneticbasisofhypercholesterolemiainadults
AT alexandraamiller geneticbasisofhypercholesterolemiainadults
AT xiaofan geneticbasisofhypercholesterolemiainadults
AT janeteolson geneticbasisofhypercholesterolemiainadults
AT davidckochan geneticbasisofhypercholesterolemiainadults
AT mayasafarova geneticbasisofhypercholesterolemiainadults
AT iftikharjkullo geneticbasisofhypercholesterolemiainadults
_version_ 1718391253924577280